Australian and UK researchers say they are closer to developing a vaccine for Group A Streptococcus after they sequenced the DNA of more than 2000 samples.

In a study in Nature Genetics, the researchers said they found detailed differences between strains of Strep A from 22 countries, but also found several molecular targets common across many strains, offering potential for vaccine development.